StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
- Status
- COMPLETED
- Phase
- PHASE2
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS
- Status
- COMPLETED
- Phase
- PHASE2
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
- Status
- UNKNOWN
- Phase
- N/A
Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML
- Status
- COMPLETED
- Phase
- PHASE2
Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PLX51107 in Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1